VEGFR
VEGFR (Vascular Endothelial Growth Factor Receptor) inhibitors are compounds that block the signaling of VEGFR, a key receptor in the VEGF pathway, which is crucial for angiogenesis. VEGFR inhibitors prevent the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby inhibiting tumor growth. These inhibitors are widely used in cancer therapy and research to study the mechanisms of angiogenesis and develop anti-cancer treatments. At CymitQuimica, we provide a comprehensive range of high-quality VEGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Read more
Axitinib
CAS:319460-85-0
Formula:
C22H18N4OS
Purity:
>95.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
386.47
Ref: 3B-A3479
| 50mg | 185.00 € |
Estimated delivery in United States, on Tuesday 20 May 2025
Regorafenib
CAS:755037-03-7
Formula:
C21H15ClF4N4O3
Purity:
>98.0%(HPLC)
Color and Shape:
White to Light yellow to Light orange powder to crystal
Molecular weight:
482.82
Ref: 3B-R0142
| 25mg | 80.00 € | ||
| 100mg | 208.00 € |
Estimated delivery in United States, on Tuesday 20 May 2025
Sorafenib Tosylate
CAS:475207-59-1
Formula:
C21H16ClF3N4O3·C7H8O3S
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
637.03
Ref: 3B-N1229
| 1g | 85.00 € |
Estimated delivery in United States, on Tuesday 20 May 2025
SKLB1002
CAS:1225451-84-2
Formula:
C13H12N4O2S2
Purity:
>98.0%(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
320.39
Ref: 3B-K0060
| 25mg | 162.00 € | ||
| 100mg | 516.00 € |
Estimated delivery in United States, on Tuesday 20 May 2025
NVP-BHG 712
CAS:940310-85-0
Formula:
C26H20F3N7O
Purity:
>95.0%(HPLC)
Color and Shape:
White to Light yellow to Light orange powder to crystal
Molecular weight:
503.49
Ref: 3B-N1099
| 10mg | 128.00 € | ||
| 50mg | 426.00 € |
Estimated delivery in United States, on Tuesday 20 May 2025
Ginsenoside Rk2
CAS:364779-14-6
Ginsenoside Rk1 has anti-tumor, and anti-platelet aggregation activities.
Formula:
C36H60O7
Color and Shape:
Solid
Molecular weight:
604.869
Ref: TM-TN1095
| 1mg | 143.00 € | ||
| 2mg | To inquire |
Estimated delivery in United States, on Friday 23 May 2025
![2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-](https://static.cymitquimica.com/products/IN/thumb/DA00298W.jpg)
2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-
CAS:204005-46-9
Formula:
C15H14N2O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
238.2845
Ref: IN-DA00298W
| 1g | 665.00 € | ||
| 10mg | 54.00 € | ||
| 50mg | 126.00 € | ||
| 100mg | 180.00 € | ||
| 250mg | 185.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Pamufetinib
CAS:1190836-34-0
Pamufetinib (TAS-115) is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase.
Formula:
C27H23FN4O4S
Purity:
99.39%
Color and Shape:
Solid
Molecular weight:
518.56
Ref: TM-T13108
| 1mg | 50.00 € | ||
| 5mg | 106.00 € | ||
| 10mg | 158.00 € | ||
| 25mg | 258.00 € | ||
| 50mg | 379.00 € | ||
| 100mg | 538.00 € | ||
| 200mg | 733.00 € | ||
| 1mL*10mM (DMSO) | 134.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
(E)-2-cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide
CAS:168835-82-3
Formula:
C25H30N2O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
390.5179
Ref: IN-DA00AO2T
| 5mg | 64.00 € | ||
| 25mg | 192.00 € | ||
| 50mg | 249.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Lenvatinib
CAS:417716-92-8
Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, …
Formula:
C21H19ClN4O4
Purity:
98.46% - 99.8000%
Color and Shape:
Solid
Molecular weight:
426.85
Ref: TM-T0520
| 5mg | 48.00 € | ||
| 10mg | 62.00 € | ||
| 25mg | 95.00 € | ||
| 50mg | 120.00 € | ||
| 100mg | 177.00 € | ||
| 500mg | 439.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Naphazoline hydrochloride
CAS:550-99-2
Naphazoline hydrochloride (Naphazoline HCl) is an adrenergic vasoconstrictor agent used as a decongestant.
Formula:
C14H15ClN2
Purity:
97.6%
Color and Shape:
White Crystalline Powder White Crystalline Powder
Molecular weight:
246.74
Ref: TM-T0446
| 1g | 34.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Chloropyramine hydrochloride
CAS:6170-42-9
Chloropyramine hydrochloride (Alergosan) is a histamine receptor H1 antagonist.
Formula:
C16H20ClN3·HCl
Purity:
99.45% - 99.8%
Color and Shape:
Solid
Molecular weight:
326.26
Ref: TM-T0263
| 25mg | 39.00 € | ||
| 50mg | 51.00 € | ||
| 100mg | 74.00 € | ||
| 200mg | 96.00 € | ||
| 1mL*10mM (DMSO) | 47.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Ref: IN-DA01DU9U
| 2mg | 112.00 € | ||
| 5mg | 148.00 € | ||
| 10mg | 166.00 € | ||
| 25mg | 317.00 € | ||
| 50mg | 524.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 27 May 2025
WHI-P154
CAS:211555-04-3
Formula:
C16H14BrN3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
376.2047
Ref: IN-DA00BF57
| 1g | 597.00 € | ||
| 10mg | 68.00 € | ||
| 50mg | 118.00 € | ||
| 100mg | 187.00 € | ||
| 250mg | 224.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
![2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluoroph…](https://static.cymitquimica.com/products/IN/thumb/DA00ICN3.jpg)
2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS:755037-03-7
Formula:
C21H15ClF4N4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
482.8154
Ref: IN-DA00ICN3
| 1g | 131.00 € | ||
| 5g | 255.00 € | ||
| 10g | 619.00 € | ||
| 25g | To inquire | ||
| 10mg | 30.00 € | ||
| 50mg | 46.00 € | ||
| 100mg | 56.00 € | ||
| 250mg | 69.00 € | ||
| 500mg | 100.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Lucitanib
CAS:1058137-23-7
Lucitanib (E-3810) is a VEGFR/FGFR inhibitor targeting VEGFR1-3 and FGFR1-2 with IC50s 7-82.5 nM.
Formula:
C26H25N3O4
Purity:
96.13%
Color and Shape:
Solid
Molecular weight:
443.49
Ref: TM-T15185
| 1mg | 48.00 € | ||
| 2mg | 63.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 144.00 € | ||
| 25mg | 269.00 € | ||
| 50mg | 487.00 € | ||
| 100mg | 710.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Sunitinib
CAS:557795-19-4
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and …
Formula:
C22H27FN4O2
Purity:
98% - 99.67%
Color and Shape:
Yellow Solid
Molecular weight:
398.47
Ref: TM-T0374L
| 100mg | 58.00 € | ||
| 200mg | 88.00 € | ||
| 500mg | 95.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Axitinib
CAS:319460-85-0
Axitinib (AG-013736) is a multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1/2/3 and PDGFRβ. Axitinib has …
Formula:
C22H18N4OS
Purity:
98.9% - 99.81%
Color and Shape:
Off-White Solid
Molecular weight:
386.47
Ref: TM-T1452
| 1g | 207.00 € | ||
| 25mg | 39.00 € | ||
| 50mg | 49.00 € | ||
| 100mg | 66.00 € | ||
| 200mg | 85.00 € | ||
| 500mg | 147.00 € | ||
| 1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Sorafenib
CAS:284461-73-0
Sorafenib (Bay 43-9006) is a multikinase inhibitor that inhibits Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, …
Formula:
C21H16ClF3N4O3
Purity:
98% - 99.89%
Color and Shape:
Solid
Molecular weight:
464.82
Ref: TM-T0093L
| 1g | 89.00 € | ||
| 50mg | 40.00 € | ||
| 100mg | 52.00 € | ||
| 500mg | 69.00 € | ||
| 1mL*10mM (DMSO) | 35.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Carvedilol phosphate hemihydrate
CAS:610309-89-2
Carvedilol phosphate hemihydrate (BM 14190 phosphate hemihydrate) is the phosphate salt form of carvedilol, a …
Formula:
C24H26N2O4·5H2O·H3O4P
Purity:
99.24%
Color and Shape:
Solid
Molecular weight:
513.49
Ref: TM-T0342
| 25mg | 37.00 € | ||
| 50mg | 48.00 € | ||
| 100mg | 55.00 € | ||
| 200mg | 73.00 € | ||
| 500mg | 87.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
